{"id":"W2757829418","doi":"10.1200/jco.2009.27.15_suppl.557","title":"Cost-effectiveness of zoledronic (ZOL) acid plus endocrine therapy (ET) in premenopausal women with early breast cancer (EBC) from a Canadian perspective","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Anastrozole; Breast cancer; Tamoxifen; Cost effectiveness; Gynecology; Goserelin; Internal medicine; Randomized controlled trial; Quality-adjusted life year; Oncology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00135896,0.0006152897,0.0008660916,0.001013229,0.0007404244,0.001470004,0.001072594,0.001127721,0.002946292],"category_scores_gemma":[0.0050696,0.0005190458,0.002087466,0.001386759,0.0005287058,0.0005396056,0.000580374,0.0008599276,0.000120463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03689665,"about_ca_system_score_gemma":0.02781367,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8800008,"about_ca_topic_score_gemma":0.8711582,"domain_scores_codex":[0.9991818,0.00033447,0.00003474777,0.0000760378,0.0001519494,0.0002209392],"domain_scores_gemma":[0.9986606,0.0006945097,0.0001946876,0.00002808117,0.0001821821,0.000240081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.009898608,0.0003459907,0.06249559,0.001046998,0.003455518,0.0005491915,0.0002041792,0.8674664,0.0008975245,0.01202176,0.005068207,0.03655001],"study_design_scores_gemma":[0.004105782,0.002284819,0.09686504,0.00071862,0.00533876,0.0006960994,0.0006474341,0.8694392,0.0006996971,0.009958766,0.009010214,0.0002355258],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9448473,0.01608332,0.003953627,0.006568517,0.00009318208,0.0006481666,0.01194519,0.00007460413,0.01578606],"genre_scores_gemma":[0.9947333,0.002023387,0.001297057,0.0002299671,0.00001213969,0.00006047313,0.001093291,0.000006373882,0.0005440945],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1199992,"threshold_uncertainty_score":0.2677051,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1041475463852387,"score_gpt":0.4916651290506259,"score_spread":0.3875175826653872,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}